MarketCap
Facebook
X
Telegram
Harpoon Therapeutics ROA | HARP
ROA Jährlich Harpoon Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -91.86 | -75.08 | -29.09 | -31.47 | -26.68 | -52.8 | -136.04 | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -26.68 | -136.04 | -63.29 |
ROA Vierteljährlich Harpoon Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -30.08 | -42.22 | -59.24 | -45.21 | -54.76 | -49.36 | -57.06 | -41.72 | -48.33 | -46.04 | -43.94 | -28.04 | -29.5 | -33.42 | -34.5 | -34.91 | -36.32 | -31.74 | -30.05 | -26.68 | -6.59 | -5.84 | -4.76 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -4.76 | -59.24 | -35.67 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Savara
SVRA
|
-46.89 | $ 5.03 | 2.24 % | $ 1.12 B |  USA |
 |
Teligent, Inc.
TLGT
|
-12.14 | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
-35.6 | - | - | $ 2.91 B | USA |
 |
TG Therapeutics
TGTX
|
42.06 | $ 65.76 | 2.33 % | $ 9.49 B | USA |
 |
Aphria Inc.
APHA
|
-3.39 | - | -0.45 % | $ 4.87 B |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
-9.61 | - | -0.90 % | $ 104 M | USA |
 |
Chiasma, Inc.
CHMA
|
-42.41 | - | -6.00 % | $ 238 M | USA |
 |
Trevi Therapeutics
TRVI
|
-22.11 | $ 14.83 | -0.57 % | $ 2 B | USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
-47.82 | - | - | $ 376 M | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
78.84 | - | 0.38 % | $ 12.9 M |  Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
-252799694827.9 | - | 2.07 % | $ 34.4 M | USA |
 |
Cerecor Inc.
CERC
|
-145.12 | - | -1.68 % | $ 283 M | USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
-28.6 | - | - | $ 1.63 B | USA |
 |
Auris Medical Holding Ltd.
EARS
|
-39.43 | - | -1.77 % | $ 39.2 M |  Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
-15.93 | - | 0.34 % | $ 2.98 B | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
-0.5 | - | 1.3 % | $ 27.7 M |  France |
 |
GW Pharmaceuticals plc
GWPH
|
-6.19 | - | - | $ 6.81 B |  Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
-66.94 | - | - | $ 1.7 B | USA |
 |
Liminal BioSciences
LMNL
|
1.23 | - | - | $ 256 M | Canada |
 |
argenx SE
ARGX
|
14.88 | $ 977.91 | 0.65 % | $ 59.9 B |  Niderland |
 |
XBiotech
XBIT
|
-30.34 | $ 1.95 | -1.02 % | $ 59.5 M | USA |
 |
Neos Therapeutics, Inc.
NEOS
|
-18.6 | - | -2.54 % | $ 57.2 M | USA |
 |
Odonate Therapeutics, Inc.
ODT
|
-75.26 | - | -3.18 % | $ 58.5 M | USA |
 |
Orphazyme A/S
ORPH
|
-76.99 | - | -2.25 % | $ 31.3 M |  Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
-21.46 | - | -10.74 % | $ 89.9 M | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
-16722.69 | - | - | $ 1.77 B | USA |
 |
Xenetic Biosciences
XBIO
|
-32.05 | $ 1.87 | 3.68 % | $ 3.18 M | USA |
 |
Viridian Therapeutics
VRDN
|
-38.09 | $ 31.22 | 1.17 % | $ 3.18 B | USA |
 |
Translate Bio, Inc.
TBIO
|
-6.04 | - | - | $ 2.81 B | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
-19.73 | - | - | $ 1.94 B | Canada |
 |
Urovant Sciences Ltd.
UROV
|
-231.84 | - | - | $ 532 M | Britain |
 |
Acceleron Pharma Inc.
XLRN
|
-13.39 | - | - | $ 10.9 B | USA |
 |
Zealand Pharma A/S
ZEAL
|
-49.24 | - | 0.52 % | $ 821 M | Danmark |
 |
Zogenix, Inc.
ZGNX
|
-32.16 | - | -4.97 % | $ 664 M | USA |
|
Yunhong International
ZGYH
|
-1.14 | - | 0.10 % | $ 92.2 M |  China |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
-54.65 | - | -7.58 % | $ 264 M | USA |
 |
Vanda Pharmaceuticals
VNDA
|
-45.1 | $ 4.17 | 2.08 % | $ 246 M | USA |
 |
Verrica Pharmaceuticals
VRCA
|
-37.98 | $ 3.88 | 10.23 % | $ 41.3 M | USA |
 |
Leap Therapeutics
LPTX
|
3.06 | - | 368.57 % | $ 41.9 M | USA |
 |
Zymeworks
ZYME
|
-54.44 | $ 29.06 | -7.64 % | $ 1.5 B | Canada |
 |
Adial Pharmaceuticals
ADIL
|
-119.54 | $ 3.15 | -35.42 % | $ 2.11 M | USA |
 |
ADMA Biologics
ADMA
|
23.54 | $ 13.19 | 4.1 % | $ 3.14 B | USA |
 |
Cortexyme
CRTX
|
-89.8 | - | -1.05 % | $ 67.1 M | USA |
 |
Burford Capital Limited
BUR
|
0.94 | $ 3.65 | 0.14 % | $ 800 M | Britain |
 |
Daré Bioscience
DARE
|
-41.26 | $ 0.71 | 2.5 % | $ 7.94 M | USA |
 |
Fate Therapeutics
FATE
|
-42.74 | $ 1.6 | -9.6 % | $ 190 M | USA |
 |
Greenwich LifeSciences
GLSI
|
-313.34 | $ 16.12 | 0.31 % | $ 218 M | USA |
 |
Halozyme Therapeutics
HALO
|
12.55 | $ 101.68 | -1.26 % | $ 12.2 B | USA |
 |
Hutchison China MediTech Limited
HCM
|
26.06 | $ 15.09 | -1.92 % | $ 13 B | China |
 |
Aptorum Group Limited
APM
|
-7.29 | - | - | $ 5.72 M | China |